These projects were made possible from Cure Alzheimer's Fund support.
Project Description | Researchers | Funding |
---|---|---|
Microglial-Specific INPP5D Knockdown Modulates Behavior, Amyloidosis and Tauopathy in Alzheimer’s Mouse Models |
2022 $217,327 |
|
VGF-Derived Peptide Therapy for Alzheimer’s Disease: Studies of Mouse and Human TLQP-21 and its Receptor, C3aR1 |
2020 $172,500 |
|
VGF, a Novel Therapeutic Effector of Alzheimer’s Disease Pathogenesis and Progression |
2017, 2019 $300,000 |